Encompass Health (EHC) reported Q3 adjusted earnings late Monday of $1.03 per diluted share, up from $0.86 a year earlier.
Analysts polled by Capital IQ expected $0.94.
Net operating revenue for the quarter ended Sept. 30 increased to $1.35 billion from $1.21 billion a year earlier.
Analysts surveyed by Capital IQ expected $1.33 billion.
For 2024, the company now expects adjusted EPS of $4.19 to $4.33 on revenue of $5.33 billion to $5.38 billion, up from its prior ranges of $3.97 to $4.22 and $5.28 billion to $5.35 billion.
The consensus is for $4.19 and $5.32 billion, respectively.
Shares of Encompass Health were up more than 5% in after-hours trading.
Price: 98.00, Change: +4.91, Percent Change: +5.27
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。